Skip to content

Index of Microcirculatory Resistance After Immediate Versus Deferred Stenting in Patients With Acute Myocardial Infarction

Index of Microcirculatory Resistance After Immediate Versus Deferred Stenting in Patients With Acute Myocardial Infarction

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03238508
Enrollment
60
Registered
2017-08-03
Start date
2013-01-01
Completion date
2017-09-30
Last updated
2017-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Keywords

Deferred stenting, Microvascular dysfunction

Brief summary

This study will compare the microcirculatory resistance (IMR) of infarct-related artery (IRA) in patients who underwent immediate versus deferred stenting during percutaneous coronary intervention (PCI) for acute myocardial infarction.

Detailed description

Primary PCI with immediate stenting (IS) is the current standard of reperfusion strategy for STEMI. However, it is thought that IS may cause additional myocardial injury by increasing distal embolization of clot and atheromatous plaque debris. Only about 35% of patients without cardiogenic shock can achieve optimal myocardial tissue perfusion at the microvascular level, even after restoration of epicardial coronary artery patency. IS in highly pro-thrombotic and inflammatory milieu of IRA during primary PCI would increase distal embolization of clot and atheromatous plaque debris, and provoke the inflammation process, so deferred stenting after a cooling down period of IRA for several days, have a potential to mitigate or prevent microvascular obstruction (MVO). Among several methods to evaluate MVO after STEMI, IMR has been well known as an good indicator of MVO and strong predictor for short and long term clinical outcomes.

Interventions

Previously described

Sponsors

Sejong General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. More than 30 minutes in duration of typical chest pain 2. Thrombolysis In Myocardial Infarction (TIMI) flow 0, 1 or 2 prior to the procedure

Exclusion criteria

1. Cardiogenic shock, 2. Previous history of myocardial infarction, or coronary artery bypass surgery 3. Rescue PCI after fibrinolysis 4. Life expectancy of less than 1 year 5. Acute occlusion of left main coronary artery 6. STEMI due to stent thrombosis 7. Major coronary dissection (type D\ F) following procedures achieving TIMI 3 flow

Design outcomes

Primary

MeasureTime frameDescription
Index of microcirculatory resistance of infarct-related artery3 to 5 days after primary reperfusion (TIMI 3 flow achievement) in both groupsMeasured by pressure and temperature sensors- tipped guide wire

Secondary

MeasureTime frameDescription
The rate of urgent revascularizationDuring index hospitalization (intraoperative)
Major bleedingDuring index hospitalization (intraoperative)Defined as TIMI bleeding criteria
Major adverse cardiac eventsOne- year after primary reperfusionDeath, myocardial infarction, unplanned target vessel revascularization or CHF admission

Countries

South Korea

Contacts

Primary ContactHyun Jong Lee, MD
untouchables@sejongh.co.kr82-32-340-1812

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026